论文部分内容阅读
目的:观察益肾和络合剂对慢性肾衰竭(CRF)实验室指标的影响。方法:将60例CRF患者随机分为两组,治疗组30例给予益肾和络合剂,对照组30例给予尿毒清颗粒,6个月后观察两组的实验室指标。结果:治疗组在用药后血肌酐(Scr)、尿素氮(BUN)、胆固醇(CH)、低密度脂蛋白(LDL)下降,高密度脂蛋白(HDL)、血清清蛋白(ALB)升高,与治疗前比较差异均有显著性(P<0.05),与对照组比较差异均有显著性(P<0.05)。结论:益肾和络合剂可以明显改善CRF患者的实验室指标,延缓CRF的进展。
Objective: To observe the effects of Yishen and complexing agents on laboratory indexes of chronic renal failure (CRF). Methods: Sixty patients with CRF were randomly divided into two groups. The treatment group was given Yishen and complexing agent, while the control group, 30 cases were treated with nimuraqing granules. The laboratory indexes of the two groups were observed after 6 months. Results: After treatment, the serum levels of Scr, BUN, CH, LDL, HDL and ALB in the treatment group decreased, Compared with the control group, the difference was significant (P <0.05), compared with the control group, the difference was significant (P <0.05). Conclusion: Yishen and complexing agents can obviously improve the laboratory indexes of CRF patients and delay the progress of CRF.